Public procurement Brussels, 15 July 2015

The provisional results of a study evaluating the functioning of Regulation 953/2003 on tiered pricing will be discussed at this workshop.

The Regulation intended to increase the availability of pharmaceuticals for the treatment of HIV/AIDs, tuberculosis and malaria in the poorest countries. It supported the sale of medicines in those countries at heavily discounted prices by offering protection against discounted medicines being re-imported into the EU. It is evaluated as part of the Commission’s regulatory fitness and performance programme.

More information on the Regulation

The provisional results of the study will be made available on 1 July on this website.

Stakeholders can provide written comments until Wednesday 22 July 2015 at the email CRAevaluation9532003@crai.com

Who can attend You are welcome to join us if you represent stakeholders such as the pharmaceutical industry and potential beneficiary countries, international organisations and civil society organisations dealing with access to medicines, and Member States, in particular authorities dealing with pharmaceutical products, health, and trade.

Meeting details

• Date: Wednesday 15 July 2015 from 09:30 – 16:30
• Venue: Rue Philippe Le Bon 3, 1000 Brussels, Belgium

Registration

Please complete the on line form by Friday 3 July.

Registration is on a first come, first served basis for the indicated stakeholders and is limited to 1 participant per organisation.

Confirmed participants will be informed by email.